SBC Medical Group (NASDAQ:SBC - Get Free Report) announced its quarterly earnings data on Friday. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01, Zacks reports. The company had revenue of $57.90 million for the quarter, compared to analyst estimates of $56.34 million.
SBC Medical Group Stock Down 4.7 %
NASDAQ:SBC traded down $0.15 during mid-day trading on Tuesday, reaching $3.04. The stock had a trading volume of 10,797 shares, compared to its average volume of 59,026. The business has a 50 day simple moving average of $4.38. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $12.50. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.76 and a current ratio of 2.79.
SBC Medical Group Company Profile
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Stories
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
